Pfizer, Inc.

PFE

US7170811035

Pharmaceuticals

Market Closed - Nyse Other stock markets 04:00:02 2024-12-06 pm EST			5-day change	1st Jan Change
25.73 ^USD	+0.12%		-1.83%	-10.63%

Dec. 05	Sector Update: Health Care Stocks Retreat Late Afternoon	MT
Dec. 05	Eli Lilly, Pfizer Executives Discuss Cancer Cures With President-Elect Trump	MT

Health Care Flat as Pfizer Weighs -- Health Care Roundup

October 29, 2024 at 06:01 pm EDT

Health-care companies were mostly flat amid mixed earnings.

Drug giant Pfizer boosted its 2024 revenue projection, alleviating pressure from activist investor Starboard Value.

Swiss drug maker Novartis raised its growth projections for the third time this year after higher third-quarter results topped expectations, boosted by revenue from its blockbuster drugs.

Write to Rob Curran at rob.curran@dowjones.com

(END) Dow Jones Newswires

10-29-24 1800ET

Stocks mentioned in the article

	Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	Price	Change	5d. change	Capi.
	NOVARTIS AG	89.81CHF	-0.63%	-3.71%	205B
	PFIZER, INC.	25.73USD	+0.12%	-1.83%	146B

Latest news about Pfizer, Inc.

Sector Update: Health Care Stocks Retreat Late Afternoon	Dec. 05	MT
Eli Lilly, Pfizer Executives Discuss Cancer Cures With President-Elect Trump	Dec. 05	MT
Trump, RFK Jr. met with Pfizer, Lilly executives, Axios reports	Dec. 05	RE
Haleon says Pfizer representative steps down from board	Dec. 05	AN
Novavax to sell Czech manufacturing unit to Novo Nordisk for $200 million	Dec. 04	RE
Pfizer Receives Authorization from Health Authority for Its 20-Valent Pneumococcal Conjugate Vaccine for Infants and Children	Dec. 03	CI
Everest Medicines Announces Acceptance of Velsipity New Drug Application in Hong Kong	Dec. 01	CI
Wall Street hit by turkey coma	Nov. 29
PFIZER INC : Berenberg remains Neutral	Nov. 29	ZD
Berenberg Adjusts Price Target on Pfizer to $29 From $27, Maintains Hold Rating	Nov. 29	MT
Analyst recommendations: Apple, Dell, Pfizer, Wall Disney, GSK...	Nov. 29
Health Care Up Amid Cyclical Bias -- Health Care Roundup	Nov. 25	DJ
GC Biopharma USA Names Sean Zam as Head of Sales and Marketing	Nov. 22	CI
Sector Update: Health Care Stocks Rise Pre-Bell Thursday	Nov. 21	MT
Zai Lab, Pfizer Collaborate for Marketing Antibacterial Drug in China	Nov. 21	MT
Zai Lab and Pfizer Announce Strategic Collaboration on the Novel Antibacterial Drug Xacduro® (Sulbactam-Durlobactam)	Nov. 21	CI
UK Tribunal Fines Pfizer, Flynn GBP69 Million For Excessive Pricing of Epilepsy Medicine	Nov. 20	MT
Health Care Climbs as Obesity-Drug Makers Rebound - Health Care Roundup	Nov. 20	DJ
US CDC expects COVID and RSV levels to increase in coming weeks	Nov. 20	RE
Pfizer, Flynn Get Fined $87.3 Million by UK Tribunal for Excessive Pricing on Epilepsy Drug	Nov. 20	MT
UK Tribunal Fines Pfizer, Flynn $87.3 Million for Excessive Pricing	Nov. 20	MT
European Equities Close Lower in Wednesday Trading; ECB Sees Elevated Financial Stability Risk	Nov. 20	MT
Top Midday Stories: Comcast to Spin Off Cable TV Networks; Target Tumbles on Q3 Earnings Miss, Lowered Full-Year Guidance	Nov. 20	MT
Global markets live: Pfizer, Alphabet, Comcast, Ford, Nokia...	Nov. 20

Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (52.3%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (25.6%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (19.9%); - other (2.2%). Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (33.8%).

Employees

88,000

Sector

Pharmaceuticals

Calendar

2025-02-03 - Q4 2024 Earnings Release (Projected)

More about the company